BRCA Variant Classification Run 4 - registration now open

Posted 9/07/2020

We are delighted to announce that registration is now open for the online individual competency assessment for BRCA variant classification (Run 4).  

  • There is no fee to participate, as Astra Zeneca has provided a grant to fund all participation costs. 
  • Please note that Astra Zeneca will not be provided with your identified assessment results.

This online competency assessment is for the classification of BRCA1 and BRCA2 gene variants related to ovarian cancer, and BRCA2 variants related to prostate cancer, and their predicted response to PARP inhibitor treatment.  

All individuals who classify the pathogenicity of BRCA variants are eligible to take part.  You can participant for BRCA variants associated with ovarian cancer and/or prostate cancer.

Please register for this individual assessment at: BRCA Variant Classification Run 4 Registration

Click on the flyer below to download a copy. 


Go to top